JJ

Jagrutiben Jaydipsinh Chauhan

Active Director Director DIN 10987669
DIN 10987669 First appointment Mar 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Jagrutiben Jaydipsinh Chauhan

Data last updated:

Jagrutiben Jaydipsinh Chauhan is a Director at Devsam Global Pharma Private Limited (since 2025).

DIN 10987669
Primary Designation Director
First Appointment 06 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Devsam Global Pharma Private Limited U46497GJ2025PTC159969
Director06 Mar 20252025Active

Board colleagues of Jagrutiben Jaydipsinh Chauhan

NameDINCompanyDesignation
Ankita Mayurkumar Thakkar10987668Devsam Global Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Devsam Global Pharma Private Limited
Premium access

Shareholding and investment profile for Jagrutiben Jaydipsinh Chauhan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jagrutiben Jaydipsinh Chauhan

Jagrutiben Jaydipsinh Chauhan currently holds 1 directorship: Devsam Global Pharma Private Limited (Director, since 06 Mar 2025).

Jagrutiben Jaydipsinh Chauhan was first appointed on 06 Mar 2025 as Director at Devsam Global Pharma Private Limited.

The current boards of Jagrutiben Jaydipsinh Chauhan's companies include Ankita Mayurkumar Thakkar (Devsam Global Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available